Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
- 31 January 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Internal and Emergency Medicine
- Vol. 16 (3), 797-798
- https://doi.org/10.1007/s11739-021-02645-8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug-drug interactionsInternal and Emergency Medicine, 2021
- Absence of relevant QT interval prolongation in not critically ill COVID-19 patientsScientific Reports, 2020
- Potential drug–drug interactions in deceased inpatientsInternal and Emergency Medicine, 2018
- Drug-related mortality among inpatients: a retrospective observational studyEuropean Journal of Clinical Pharmacology, 2016
- Prevalence of fatal adverse drug reactions in hospitalized patientsInternational journal of clinical pharmacology and therapeutics, 2009